T&R Biofab Co., Ltd. (KOSDAQ:246710)

T&R Biofab Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023
Operating Revenue	14,817	4,874	5,199
Other Revenue	-0	-	-0
Revenue	14,817	4,874	5,199
Revenue Growth (YoY)	-	-6.26%	-
Cost of Revenue	11,632	2,766	4,151
Gross Profit	3,186	2,108	1,048
Selling, General & Admin	7,961	7,230	7,024
Research & Development	4,639	5,510	4,399
Amortization of Goodwill & Intangibles	187.54	83.77	61.8
Other Operating Expenses	174.01	172.15	227.69
Operating Expenses	14,360	15,407	13,902
Operating Income	-11,174	-13,299	-12,853
Interest Expense	-3.08	-2.2	-3.24
Interest & Investment Income	743.31	1,227	1,676
Currency Exchange Gain (Loss)	-144.31	7.49	0.97
Other Non Operating Income (Expenses)	1,207	8,044	-1,424
EBT Excluding Unusual Items	-9,371	-4,023	-12,604
Gain (Loss) on Sale of Investments	3,687	-517.37	5.26
Gain (Loss) on Sale of Assets	-13.4	-5.8	-0.14
Asset Writedown	-	-	-195.49
Other Unusual Items	-2,961	-3,133	-625.01
Pretax Income	-8,658	-7,679	-13,419
Net Income	-8,658	-7,679	-13,419
Net Income to Common	-8,658	-7,679	-13,419
Shares Outstanding (Basic)	4	4	4
Shares Outstanding (Diluted)	4	4	4
Shares Change (YoY)	-	1.59%	-
EPS (Basic)	-2008.73	-1782.41	-3164.24
EPS (Diluted)	-2008.73	-1782.41	-3164.24
Free Cash Flow	-13,687	-14,309	-19,456
Free Cash Flow Per Share	-3175.46	-3321.44	-4587.87
Gross Margin	21.50%	43.24%	20.16%
Operating Margin	-75.41%	-272.87%	-247.22%
Profit Margin	-58.43%	-157.56%	-258.10%
Free Cash Flow Margin	-92.37%	-293.60%	-374.22%
EBITDA	-7,520	-10,895	-10,697
EBITDA Margin	-50.75%	-223.55%	-205.74%
D&A For EBITDA	3,654	2,404	2,156
EBIT	-11,174	-13,299	-12,853
EBIT Margin	-75.41%	-272.87%	-247.22%
Advertising Expenses	-	390.07	267.47

Source: S&P Global Market Intelligence. Standard template. Financial Sources.